Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Zydus Cadila First Off The Block In NASH After India Approval
US Phase III Trials To Begin Q2 FY21
Mar 06 2020
•
By
Vibha Ravi
and
Anju Ghangurde
India Approves Cadila's NASH Drug • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from India
More from Focus On Asia